Clinical Trial Update: A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605 [Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 3 clinical trial evaluating HCP1401 for stage 2 hypertension in patients not controlled by HCP0605.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• HCP0605
• HCP1401

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Hypertension | Phase 3 | Status: COMPLETED